Equity LifeStyle Properties (ELS) presented at the BofA NY Global Real Estate Conference, where CEO Marguerite Nader highlighted the company's strong financial performance. ELS is on track to meet its guidance for the current quarter and the full year. The company emphasized that its core Net Operating Income (NOI) and normalized Funds From Operations (FFO) growth significantly exceed the REIT industry average, along with superior dividend growth and lower exposure to floating rate debt. The discussion also touched upon the long-term demand outlook for manufactured housing, driven by affordability and demographic trends.
For readers following Equity LifeStyle Properties, here is Pluang's market snapshot as of Sep 16, 2026 06:41 WIB: of 22 priced Real Estate-sector US stocks tradable on Pluang, 11 rose and 11 fell today. LTC Properties Inc (LTC) was up 1.92% at USD 43.46, and Extra Space Storage, Inc. (EXR) was up 1.51% at USD 139.72. Apartment Investment and Management Co (AIV) was down 1.46% at USD 2.37.
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
The global insurtech market is projected to grow from $14 billion today to $638 billion by 2035, at a compound annual growth rate of 41.45%. This rapid expansion is fueled by the adoption of AI, blockchain, cloud computing, machine learning, IoT, and...
The global market for wiring harnesses and connectors in electric vehicles is projected to grow from $8.53 billion in 2025 to $29.43 billion by 2035, at a CAGR of 12.83%. This growth is fueled by increasing EV production, adoption of battery electric...
The global Decentralized Clinical Trials (DCT) market, valued at $8.8 billion in 2025, is projected to grow to $18.8 billion by 2030, expanding at a CAGR of 13.7%. Growth is fueled by adoption of AI, wearables, cloud platforms, and flexible remote st...
